Ensysce Biosciences, Inc. Profile Avatar - Palmy Investing

Ensysce Biosciences, Inc.

Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activate…

Biotechnology
US, La Jolla [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of ENSC's Analysis
CIK: - CUSIP: 293602108 ISIN: US2936024056 LEI: - UEI: -
Secondary Listings
ENSC has no secondary listings inside our databases.